Enliven Therapeutics shares owned by OrbiMed Advisors
Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by OrbiMed Advisors
from 13F filings
Historical chart of OrbiMed Advisors investment in Enliven Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Enliven Therapeutics held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Enliven Therapeutics by OrbiMed Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $163M | 8.0M | 20.47 |
| 2025-06-30 | $160M | 8.0M | 20.06 |
| 2025-03-31 | $157M | 8.0M | 19.68 |
| 2024-12-31 | $179M | 8.0M | 22.50 |
| 2024-09-30 | $203M | 8.0M | 25.54 |
| 2024-06-30 | $186M | 8.0M | 23.37 |
| 2024-03-31 | $158M | 9.0M | 17.59 |
| 2023-12-31 | $125M | 9.0M | 13.84 |
| 2023-09-30 | $123M | 9.0M | 13.66 |
| 2023-06-30 | $184M | 9.0M | 20.41 |
| 2023-03-31 | $197M | 9.0M | 21.90 |